AO G.Rummo

Benevento 82100

0 studies enrolling now · 2 studies all time

What they study most

HER-2 Positive Breast Cancer, Metastatic Neoplasm, Non-small Cell Lung Cancer

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label — Stopped early